Recursion to buy AI-enabled drug discovery startups Cyclica, Valence
Recursion agreed to buy Toronto-based Cyclica for $40 million and Montreal-based Valence for $47.5 million.
8 May 2023•2 mins read
Recursion agreed to buy Toronto-based Cyclica for $40 million and Montreal-based Valence for $47.5 million.
